APIS Assay Technologies Ltd expands bioinformatics expertise with acquisition of Beogenomics Image caption: Inside the laboratories at APIS – a Class 2 safety cabinet, where the company handles infectious material or potentially infectious materials. Manchester, UK — Life Science Newswire — APIS Assay Technologies Ltd, a company combining outstanding In Vitro Diagnostics (IVD) experience with […]
TAMPA, Fla. — M2GEN announced today the launch of its oncology-focused Bioinformatics Support Services. Leveraging the results and knowledge gained from the ORIEN Avatar® Program, an extensive, unique and ever-growing oncology clinico-genomics dataset, the M2GEN Bioinformatics team provides bioinformatics support services adhering to best-in-class standards. M2GEN offers the following bioinformatics services: Paired Tumor and Germline Whole […]
Among the many lessons learned from the COVID-19 pandemic is that the world remains dangerously exposed to the novel and unknown health risks, despite exponential developments in our ability to improve and prolong life. Access to the right data could help scientists develop faster responses not only for global pandemics, but also for long-term improvements in […]
Enterprise software solution addresses industry challenges in characterizing novel and complex biotherapeutic molecules and monitoring their critical quality attributes Basel, Switzerland – Genedata, a leading provider of enterprise software solutions for biopharmaceutical R&D, today announced the release of Genedata Expressionist® 14.0. The market-leading platform for mass spectrometry-based biotherapeutic characterization and quality monitoring is valued by the […]
• QIAseq SARS-CoV-2 Primer Panel converts viral RNA samples into libraries ready for sequencing • QIAGEN Digital Insights solutions support COVID-19 drug, vaccine and epidemiology research Hilden, Germany, and Germantown, Maryland – QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) launched the innovative QIAseq SARS-CoV-2 Primer Panel for next-generation sequencing (NGS) of the novel coronavirus genome, along with […]
Major platform advancements demonstrate applicability of biosimulation to accelerate drug discovery and development PRINCETON, NJ – Certara®, the global leader in biosimulation, today announced the development of a new biosimulation platform for COVID-19 vaccines and major enhancements in its Immunogenicity and Immuno-oncology QSP platforms. Certara has partnered with leading, global pharmaceutical companies on these advancements to […]
New solution to remove some of the current unknowns about the virus Boston & Lausanne, Switzerland: SOPHiA GENETICS, leader in Data-Driven Medicine, launches a first-of-its-kind multimodal solution to predict COVID-19 disease evolution, opening new dimensions of insight into the fight against the worldwide pandemic. This advancement goes beyond genomics, analyzing a wider spectrum of data […]
Combination of experts and software helps accelerate pediatric drug development and increase clinical trial success rates PRINCETON, NJ – Today, Certara®, the global leader in biosimulation, launches Certara Pediatrics, a new practice area to help biopharmaceutical companies apply model-informed drug development to their pediatric programs and better navigate the changing regulatory landscape. Certara Pediatrics brings together Certara’s […]
Merck KGaA, Darmstadt, Germany Selects Cambridge Semantics as Enterprise Data Fabric Provider Cambridge Semantics Aiding Merck KGaA, Darmstadt, Germany in Modernizing its Data Integration Capabilities and in Forging Multiple Data-driven Initiatives Business Wire BOSTON — Cambridge Semantics, the leading provider of modern, graph-driven data integration for the enterprise data fabric, today announced that Merck KGaA, […]
Cambridge, United Kingdom – Congenica, a digital health company enabling rapid analysis of complex genomic data, has launched an update for its clinical decision support platform that will provide automated classification, evidence and reporting of recurrent ‘known’ variants that customers observe in their rare disease cases, significantly saving time while maximizing diagnostic yield and laboratory throughput. The […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
